| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c565aa4bc6fa0103046a40406a4bea57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f02aec95f5fa4a51fb366f2190e679e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_765a3d39cdd2595157fb072678ff4015 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aec5486c5c0945e516703fcb1290d53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ecf2b3bf60cee00d26550c7e6fad7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0459ee97b95f56f4777329fd1bb94820 |
| publicationDate |
2010-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010073257-A1 |
| titleOfInvention |
An immunodominant b-cell epitope based protein vaccine against anthrax and method of preparation thereof |
| abstract |
The present invention relates to the development of immunodominant B-cell epitope based protein vaccine having SEQ ID No.: 1 eliciting immune response against anthrax. The invention also relates to a polynucleotide sequence having SEQ ID No.: 2 encoding epitope based protein vaccine. The invention also relates to the method of preparation and purification of epitope based protein vaccine. The present invention further relates to vaccine composition of B-cell epitope based protein vaccine against anthrax, its method of preparation and process of using the composition. The vaccine or the vaccine composition of the present invention generates high titers of antibodies having high affinity and avidity and are highly effective in in vitro neutralization of B . anthracis lethal toxin and conferring protection against in vivo lethal toxin challenge. |
| priorityDate |
2008-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |